For instance, the potent JNJ-47965567 [48] totally failed in altering the survival, disease progression, and the molecular and cellular parameters of ALS in SOD1-G93A mice when compound administration was performed three times per week from the early symptomatic phase [32]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.